CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bio-Thera Solutions Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bio-Thera Solutions Ltd
No. 18 Spiral 2nd Road
International Bio Island
Phone: +86 2032203528p:+86 2032203528 GUANGZHOU, GNG  510005  China Ticker: 688177688177
Business Summary
Bio-Thera Solutions Ltd is a China-based company primarily engaged in the research and development of innovative drugs and biosimilars. The Company’s main products include QLETLI (adalimumab), POBEVCY (bevacizumab), TOFIDENCE (tocilizumab), BETAGRIN (bevifibatide citrate) and other products. The Company’s products are mainly used for the treatment of cancer, autoimmune diseases, cardiovascular diseases, ophthalmic conditions, and other illnesses. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ShengfengLi 66 5/1/2022 3/5/2019
Chief Financial Officer XianhongZhan 44 4/19/2019 4/19/2019
Deputy General Manager, Director CaiBao 39 4/30/2025 3/4/2021
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,167 (As of 12/31/2023)
Outstanding Shares: 414,080,000 (As of 6/30/2025)
Shareholders: 7,927
Stock Exchange: SHA
Fax Number: +86 2032203218


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 24, 2025